Outcome of Peptic Ulcer Bleeding, Nonsteroidal Anti-inflammatory Drug Use, and Helicobacter pylori Infection
Authors:
- Monique E. van LeerdamMLMonique E. van Leerdam
- Erik A.J. RauwsERErik A.J. Rauws
- Guido N.J. TytgatGTGuido N.J. Tytgat
- 1 September 2005
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 3 (9) , 859-864
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Peptic-ulcer diseaseThe Lancet, 2002
- Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low‐dose aspirinAlimentary Pharmacology & Therapeutics, 2002
- Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleedingAlimentary Pharmacology & Therapeutics, 2002
- The effect of Helicobacter pylori infection on nonsteroidal anti‐inflammatory drug‐induced upper gastrointestinal tract injuryAlimentary Pharmacology & Therapeutics, 2002
- Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysisThe Lancet, 2002
- Clinical and endoscopic characteristics of non‐Helicobacter pylori, non‐NSAID duodenal ulcers: a long‐term prospective studyAlimentary Pharmacology & Therapeutics, 2001
- H. pylori-Negative Duodenal Ulcer Prevalence and Causes in 774 PatientsDigestive Diseases and Sciences, 1999
- Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: A case-control study☆, ☆☆Gastroenterology, 1999
- Comparison of invasive and noninvasive tests for detecting Helicobacter pylori infection in bleeding peptic ulcersGastrointestinal Endoscopy, 1999
- ENDOSCOPY IN GASTROINTESTINAL BLEEDINGThe Lancet, 1974